FDA Approved: CABERGOLINE — Supplemental Application (SOLA Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved SOLA Pharmaceuticals’ supplemental application for cabergoline (generic), granting approval for commercialization of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Prolactinoma

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)